Saturday, July 21, 2018 8:37:29 AM
But it was mismanaged early on by people with know-how inappropriate to the task (Fowler, Reiza, Hargrove, Randall, and others).
Yet here we are; if we were in the hands of a large medical tech company for the past two years or so, we would already be in FDA testing and reaping the share price benefits of becoming the first competitor to ISRG.
My guess at this point is that McNally will be forced to sell the entire package to someone (for a firesale price)just so the "principals" can walk off with their profit. There it will either fizzle out (ie. bogged down with lawsuits from Columbia, MicroLine, Ximedica, shareholders,or actually become a dominant product).
PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM